$18.41
+0.14 (+0.77%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+53.29%
1Y
+1,215.00%
YTD
+412.81%
Open$18.61
Previous Close$18.27
Day High$18.80
Day Low$17.83
52W High$24.28
52W Low$1.33
Volume—
Avg Volume3.42M
Market Cap6.39B
P/E Ratio—
EPS$-0.93
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$7.48
Above
SMA 200
$3.25
Above
RSI (14)
71.9
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
+33.9% upside
Current
$18.41
$18.41
Target
$24.65
$24.65
$19.75
$24.65 avg
$31.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 897.62M | 918.48M | 827.43M |
| Net Income | -100,463,137 | -95,918,574 | -115,001,691 |
| Profit Margin | -11.2% | -10.4% | -13.9% |
| EBITDA | -104,291,949 | -115,509,109 | -110,721,792 |
| Free Cash Flow | -130,963,293 | -137,514,931 | -125,568,165 |
| Rev Growth | +16.3% | +1.8% | +8.3% |
| Debt/Equity | 0.25 | 0.25 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |